Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing
Journal of Personalized Medicine · 29.03.2024 · 14 (4) · 366
DOI: 10.3390/jpm14040366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Personalized Medicine, online erschienen am 29.03.2024. Verfasst von Miruna Gug und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study represents our second investigation into NIPT, involving a more extensive patient cohort with a specific emphasis on the high-risk group. The high-risk group was subsequently divided into two further groups to compare confirmed cases versus unconfirmed via direct methods. The methodology encompassed the analysis of 1400 consecutive cases from a single genetic center in western Romania, where NIPT was used to assess the risk of specific fetal chromosomal abnormalities. All high-risk cases underwent validation through direct analysis of fetal cells obtained via invasive methods, including chorionic villus sampling and amniocentesis. The confirmation process utilized QF-PCR, karyotyping, and SNP-Array methods customized to each case. Results: A high risk of aneuploidy at NIPT was identified in 36 out of 1400 (2.57%) cases and confirmed in 28 cases. The study also detected an increased risk for copy number variations (CNVs) in 1% of cases, confirmed in two instances involving one large microdeletion and one large microduplication. Trisomy 21 was the exclusive anomaly where NIPT confirmed all cases with identified risk. High-risk NIPT results which were not validated by invasive methods, were classified as false positives; parents in these cases determined to continue the pregnancy. In conclusion, NIPT can serve as a screening method for all pregnancies; however, in high-risk cases, an invasive confirmation test is strongly recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Medical Genetics Office Dr. Gug, 300200 Timisoara, Romania.
- Department of Obstetrics and Gynecology II, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Timisoara Municipal Emergency Clinical Hospital, 300202 Timisoara, Romania.
- Department of Microscopic Morphology, Discipline of Genetics, "Victor Babeş" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
- Genomic Medicine Centre, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
ORCID-Profile: Nicoleta Andreescu
Zitieren
APA
Gug, M., Rațiu, A., Andreescu, N., Farcaș, S., Laitin, S., & Gug, C. (2024). Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing. Journal of Personalized Medicine, 14(4), 366. https://doi.org/10.3390/jpm14040366
Vancouver
Gug M, Rațiu A, Andreescu N, Farcaș S, Laitin S, Gug C. Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing. Journal of Personalized Medicine. 2024;14(4):366. doi:10.3390/jpm14040366
BibTeX
@article{Gug2024,
author = {Gug, Miruna and Rațiu, Adrian and Andreescu, Nicoleta and Farcaș, Simona and Laitin, Sorina and Gug, Cristina},
title = {Approach and Management of Pregnancies with Risk Identified by Non-Invasive Prenatal Testing},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {4},
pages = {366},
doi = {10.3390/jpm14040366}
}
EUVIMED